494 filings
Page 4 of 25
6-K
jivpqo1wf1yuc
16 May 23
Altamira Therapeutics Provides Business Update, Reports FY 2022 Financial Results
4:30pm
6-K
g961u
2 May 23
Convertible Loan Agreement
8:30am
NT 20-F
3qnzlr
1 May 23
Notice of late annual filing (foreign)
4:59pm
SC 13D/A
3n2moz
27 Apr 23
Altamira Therapeutics / Meyer Thomas ownership change
4:30pm
6-K
t6ze7g7eky5zw
18 Apr 23
Report of Foreign Private Issuer
8:00am
CERT
kwuapym3n 5r62d8eu
17 Apr 23
Certification of approval for exchange listing
12:21pm
6-K
totp1q6i3w 0bbgq40v
13 Apr 23
Report of Foreign Private Issuer
9:05am
RW
2q367scdh
13 Apr 23
Registration withdrawal request
8:20am
CERT
1qewl48y3l0q8o 5oy6p
12 Apr 23
Certification of approval for exchange listing
5:01pm
8-A12B
o2eytk9axxf c3mtdspq
11 Apr 23
Registration of securities on exchange
4:01pm
FWP
vuq7w7
11 Apr 23
Free writing prospectus
4:01pm
6-K
xo01ooc5lv6um2t
3 Apr 23
Report of Foreign Private Issuer
3:00pm
EFFECT
jgwpziar
3 Apr 23
Notice of effectiveness
12:15am
CORRESP
rfqdem06278nncio
31 Mar 23
Correspondence with SEC
12:00am
CORRESP
6661b 4ai
31 Mar 23
Correspondence with SEC
12:00am
CORRESP
0yifxggschf
31 Mar 23
Correspondence with SEC
12:00am
CORRESP
zfz68n chn
31 Mar 23
Correspondence with SEC
12:00am
F-1/A
hsb1m 0jge9
27 Mar 23
Registration statement (foreign) (amended)
10:33am
FWP
g4y6t
23 Mar 23
Free writing prospectus
8:00am